Occupy Corporatism
by Susanne Posel
Colgate Total toothpaste has been found to contain a chemical called Triclosan; an antibacterial and antifungal agent added to many consumer products such as:
• Soaps
• Shampoos
• Cosmetics
• First-Aid / Antiseptics
• Deodorants
• Toothpaste
• Mouth wash
• Clothes
• Keyboard / Mouse pad
• Kitchen utensils
• Toys
• Mops
• Blankets
• Paint
• Humidifiers
• Bedding
• Socks
• Trash bags
Colgate – Palmolive states : “Colgate Total is clinically proven to work better than other toothpastes to reduce these germs that can cause the gum disease gingivitis.”
Back in 2011, Colgate – Palmolive removed triclosan from their soap products such as Dial Complete because of “changing consumer preferences”.
Triclosan causes several adverse effects including:
• Abnormalities with the endocrine system, particularly with thyroid hormone signaling
• Weakening of the immune system
• Birth defects
• Infertility
• Uncontrolled cell growth
• Unhealthy weight loss
Thomas DiPiazza, spokesperson for Colgate – Palmolive stated: “There isn’t enough evidence to justify going back to the drawing board with its toothpaste formula. In the nearly 18 years that Colgate Total has been on the market in the U.S., there has been no signal of a safety issue from adverse-event reports.”
Until recently, the Food and Drug Administration (FDA) withheld information about the toxicological effects of triclosan which revealed that the regulatory agency relied on “company-backed science” to prove that the products worked as claimed and were safe for the general public to use.
Earlier this year, researchers from from Yale University (YU) School of Medicine have published a study examining how the FDA approves products and found that it is quite common for the agency to take the word of the corporation seeking approval rather than prove independently that products are safe.
Joseph Ross, co-author of the study, said : : “Less than half of drugs are compared to an existing alternative that’s available on the market today at the time of approval. The FDA is doing a good job of maintaining these flexible approval standards and tailoring each approval appropriately. So we can have these flexible standards that allow shorter trials and less certain trials to go forward and be the basis of an FDA approval so long as we’re continuing to study these medications in the post market period.”
Shockingly, the research observed that “fewer than half the drugs specified for long–term use are studied for more than six months.”
Ross showed that a significant portion of the medical treatments approved by the FDA are not safe nor are they thoroughly tested.
While some drugs under went severe scrutiny, others were never compared to existing treatments to judge their effectiveness.
Indeed, 37% of drugs were allowed to go to consumers with only having to withstand one clinical trial.
It was shown that:
- 91% of approvals based on a surrogate endpoint ; meaning that the drug appeared to work
- 74% of approvals based on a single trial
- 77% of approvals based on only 2 trials
- 50% of approvals based on 3 or more trials
Historically, triclosan was introduced to the public more than 4 decades ago with the allowance by the FDA to be used as a surgical scrub in hospitals.
House Representative Edward Markey received a letter from the FDA 3 years ago concerning the “effect of repetitive daily human exposure to these antiseptic ingredients.”
